You have 9 free searches left this month | for more free features.

stage II verrucous carcinoma of the larynx

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous

Recruiting
  • Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
  • +50 more
  • transoral robotic surgery
  • quality of life assessment
  • Columbus, Ohio
    Ohio State University Medical Center
Oct 28, 2022

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Stage III

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +11 more
  • KEYTRUDA®
  • (no location specified)
Nov 17, 2023

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +35 more
  • PI3K inhibitor BKM120
  • cetuximab
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Sep 14, 2021

Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell

Active, not recruiting
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +29 more
  • Cytology specimen
  • Laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Aug 31, 2021

Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IVA

Withdrawn
  • Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
  • +6 more
  • hypofractionated radiation therapy
  • +3 more
  • New Brunswick, New Jersey
  • +1 more
Sep 27, 2022

Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell

Terminated
  • Stage III Squamous Cell Carcinoma of the Hypopharynx
  • +11 more
  • cetuximab
  • +3 more
  • Newark, New Jersey
    New Jersey Medical School
Apr 19, 2021

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Salivary Gland Squamous Cell Carcinoma, Stage 0

Completed
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +57 more
  • placebo
  • +3 more
  • Columbus, Ohio
    Ohio State University Medical Center
Feb 18, 2020

Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell

Terminated
  • Stage III Squamous Cell Carcinoma of the Hypopharynx
  • +11 more
  • erlotinib hydrochloride
  • +10 more
  • Cleveland, Ohio
    Case Medical Center, University Hospitals Seidman Cancer Center,
May 6, 2020

Glottic Carcinoma Trial in Dallas (Radiation therapy)

Active, not recruiting
  • Glottic Carcinoma
  • Radiation therapy
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Feb 10, 2022

Head Neck Cancer, Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous

Completed
  • Head and Neck Cancer
  • +19 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
Mar 6, 2020

Laryngeal Carcinoma Trial in Dallas (LT-SABR, IMRT)

Not yet recruiting
  • Laryngeal Carcinoma
  • LT-SABR
  • IMRT
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Oct 6, 2023

Stage IIIA Hepatocellular Carcinoma Trial (Radiotherapy combined with TKI and Anti-PD-1 Antibody)

Not yet recruiting
  • Stage IIIA Hepatocellular Carcinoma
  • Radiotherapy combined with TKI and Anti-PD-1 Antibody
  • (no location specified)
Sep 24, 2023

Hepatocellular Carcinoma Trial in Shanghai (Cadonilimab+TACE)

Active, not recruiting
  • Hepatocellular Carcinoma
  • Shanghai, Shanghai, China
    Eastern hepatobilliary surgery hospital
Jun 21, 2023

Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, Clinical

Not yet recruiting
  • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
  • +11 more
  • Acupressure Therapy
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 12, 2023

Laryngeal Squamous Cell Carcinoma, Stage II Laryngeal Cancer AJCC v8, Stage III Laryngeal Cancer AJCC v8 Trial in Houston

Recruiting
  • Laryngeal Squamous Cell Carcinoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022

Nasopharyngeal Carcinoma, Nasopharyngeal Tumors, Nasopharyngeal Diseases Trial in Guangzhou (Nimotuzumab, Cisplatin)

Recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 3, 2022

Hepatocellular Carcinoma by BCLC Stage Trial in Guangzhou (Bevacizumab Biosimilar QL 1101)

Not yet recruiting
  • Hepatocellular Carcinoma by BCLC Stage
  • Bevacizumab Biosimilar QL 1101
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 20, 2023

Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and

Recruiting
  • Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
  • +4 more
  • Cemiplimab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 17, 2023

Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,

Not yet recruiting
  • Limited Stage Lung Small Cell Carcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Nov 10, 2023

Laryngeal Cancer Stage II, Laryngeal Cancer Stage III, Carcinoma, Squamous Cell Trial in Amsterdam (radiotherapy, Olaparib)

Active, not recruiting
  • Laryngeal Cancer Stage II
  • +3 more
  • Amsterdam, Netherlands
    The Netherlands Cancer Institute
Sep 27, 2022

Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer Trial in Nashville (drug, biological, radiation, procedure)

Not yet recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • Stage IV Lung Cancer
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Oct 25, 2023

Nasopharyngeal Carcinoma Trial in Guangzhou (mobile platform or not mobile platform)

Recruiting
  • Nasopharyngeal Carcinoma
  • mobile platform or not mobile platform
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Apr 17, 2023

Squamous Cell Carcinoma of Head and Neck Trial in Houston (Control Group, TTI-101)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Houston, Texas
    M D Anderson Cancer Centerl
Apr 25, 2023

Carcinoma, Hepatocellular, Hepatic Carcinoma, Hepatocellular Cancer Trial in Hannover (Nivolumab, TACE)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • +2 more
  • Hannover, Germany
    Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
Nov 21, 2022

Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication

Completed
  • Caregiver
  • +37 more
  • Communication Intervention
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 14, 2022